Treatment of DM2 to-day. Should we change priorities? Conclusions based on recent clinical studies
This work is devoted to the analysis of results of recent clinical studies. It is argued that the absence of close association between normalized glycemiaand reduced incidence of cardiovascular disorders may be due to both relatively short duration of observations and possible effect of co-factors (...
Guardado en:
Autor principal: | Aleksey Vadimovich Zilov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de6b76ba789e4d36a4c763e232a030f5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Glibenclamide therapy: pros and cons
por: Olga Konstantinovna Vikulova, et al.
Publicado: (2011) -
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2012) -
Sulfonylureas in the modern strategy of therapy of type 2 diabetes
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011) -
The frequency of hypoglycemia and cardiovascular disorders during therapy with sulfonylureas compared with other secretagogues: a systematic review
por: Aleksey Vadimovich Zilov, et al.
Publicado: (2010) -
Leading causes of death and concomitant pathology in patients with type 2 diabetes mellitus according to autopsy data
por: Anna Leont'evna Terekhova, et al.
Publicado: (2011)